4
Changes in Ownership
KYNTRA BIO, INC. Filed Acc 0001209191-19-055866
Director sold 6,000 shares at an average $38.27 ($229,624)
- Director acquired 6,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Kurkijarvi Kalevi · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-11-07 | Exercise or conversion : show line 1 in the form | +6,000 | $9.78 | $58,650 | 34,400 | D |
| 2019-11-07 | Sale : show line 2 in the form | −4,514 | $38.08 | $171,893 | 29,886 | D |
| 2019-11-07 | Sale : show line 3 in the form | −1,486 | $38.85 | $57,731 | 28,400 | D |
| Open-market sales · 6,000 sh · avg $38.27 · $229,624 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2019-11-07 | Exercise or conversion : show line 4 in the form Stock Option (Right to Buy) | −6,000 | $9.78 | 2023-04-17 | 6,000 | 0 | D |
Loading xslF345X03/doc4.xml…